期刊
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE
卷 16, 期 -, 页码 -出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/17534666221099737
关键词
clinically meaningful change; cough-related quality of life; Leicester Cough Questionnaire; patient-reported outcomes
资金
- Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
This study assessed the psychometric properties of the Leicester Cough Questionnaire (LCQ) and found it to be a valid and reliable measure for evaluating cough-specific quality of life in patients with chronic cough. The results can guide treatment decisions and drug development, with a specific threshold increase in the LCQ total score considered as clinically meaningful change.
Introduction: The Leicester Cough Questionnaire (LCQ), a cough-specific quality-of-life measure, evaluates the impact of cough across physical, psychological, and social domains in patients with chronic cough (CC). This study assessed the psychometric properties of the LCQ. Methods: Data from a phase IIb, randomized controlled trial of the P2X3-receptor antagonist gefapixant were analyzed (NCT02612610). Subjective [Cough Severity Diary, cough severity visual analogue scale, and patient global impression of change (PGIC)] and objective (awake and 24-h cough frequency) data were used to validate the LCQ for use in patients with refractory or unexplained CC (RCC and UCC, respectively). Psychometric analyses included confirmatory factor analyses, internal consistency and test-retest reliability, validity, responsiveness, and estimated within-patient thresholds for clinically meaningful change. Results: Model-fit values for the proposed three-factor LCQ domains and most individual items were acceptable. Analyses suggest that a mean improvement ranging from 1.3 to 2.3 points for the LCQ total and >= 0.8, >= 0.9, and >= 0.8 points for physical, psychological, and social domain scores, respectively, had the best sensitivity and/or specificity for predicting patient ratings of improvement on the PGIC. Conclusions: The LCQ is a valid and reliable measure to evaluate cough-specific quality of life and is a fit-for-purpose measure for use in patients with RCC or UCC. Although a single threshold for defining clinically meaningful change depends on the context of use, the results can help guide both treatment decisions and drug development. Therefore, clinicians may consider a >= 1.3-point increase in the LCQ total score as clinically meaningful.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据